Literature DB >> 31362570

Invasive stratified mucin-producing carcinoma: a clinicopathological analysis of three cases.

Ruixue Lei1.   

Abstract

Objective: To investigate the clinicopathologic features and immunophenotype of invasive-stratified mucin-producing carcinoma (ISMC).
Methods: We retrospectively analyzed three patients who underwent surgery for pathologically confirmed ISMC from January 2017 to December 2017 in Anyang Tumor Hospital. The pathological features, immunophenotype, and prognosis were discussed.
Results: Clinical symptoms and imaging were atypical. Microscopically, the arrangement of tumor cells is close to that of squamous cell carcinoma, showing flake or nested growth. Morphologically, tumor cells were reminiscent of adenocarcinoma. The tumor cells showed abundant intracytoplasmic mucus which routinely created spacing between adjacent nuclei. The nuclei was round or oval with irregular karyotypes, thick nuclear membrane, staining empty light, rough chromatin, visible small nucleoli. Mucous vacuoles or pink-stained foam were visible in the cytoplasm. Mitotic features and apoptotic bodies were seen in the invasive component of all three cases, whereas all but one of these showed a neutrophil-dominant inflammatory cells infiltration. A large number of histocytes were found in the stroma of two cases. Special staining of mucus confirmed the presence of mucus in cytoplasm. Immunohistochemical results showed that tumor cells were strongly and diffusely positive for p16 and CK7 and had high Ki-67 expression. Conclusions: ISMC is a rare tumor in female genital tract and is often misdiagnosed as squamous cell carcinoma and other cervical cancers. The diagnosis mainly depends on the unique clinicopathologic features together with the immunophenotype. Treatment and prognosis, like other cervical cancer, are mainly based on clinical stages.

Entities:  

Keywords:  Invasive stratified mucin; cervical cancer; immunohistochemistry; producing carcinoma; producing intraepithelial lesion; stratified mucin

Year:  2019        PMID: 31362570      PMCID: PMC6804803          DOI: 10.1080/15384047.2019.1647054

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  15 in total

1.  Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia?

Authors:  J J Park; D Sun; B J Quade; C Flynn; E E Sheets; A Yang; F McKeon; C P Crum
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

2.  Glassy cell carcinoma of the cervix.

Authors:  P Littman; P B Clement; B Henriksen; C C Wang; S J Robboy; P D Taft; H Ulfelder; R E Scully
Journal:  Cancer       Date:  1976-05       Impact factor: 6.860

3.  Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study.

Authors:  Zhong Jiang; Peigou G Chu; Bruce A Woda; Kenneth L Rock; Qin Liu; Chung-Cheng Hsieh; Cuizhen Li; Wengang Chen; Hai Ou Duan; Scott McDougal; Chin-Lee Wu
Journal:  Lancet Oncol       Date:  2006-07       Impact factor: 41.316

4.  Stratified mucin-producing intraepithelial lesion (SMILE): report of a case series with associated pathological findings.

Authors:  David P Boyle; W Glenn McCluggage
Journal:  Histopathology       Date:  2015-01-15       Impact factor: 5.087

5.  IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression.

Authors:  Cuizhen Li; Kenneth L Rock; Bruce A Woda; Zhong Jiang; Armando E Fraire; Karen Dresser
Journal:  Mod Pathol       Date:  2006-12-22       Impact factor: 7.842

6.  Stratified mucin-producing intraepithelial lesion with invasive carcinoma: 12 cases with immunohistochemical and ultrastructural findings.

Authors:  Junji Onishi; Yuichiro Sato; Akira Sawaguchi; Atsushi Yamashita; Kazunari Maekawa; Hiroshi Sameshima; Yujiro Asada
Journal:  Hum Pathol       Date:  2016-05-27       Impact factor: 3.466

7.  Glassy cell carcinoma of the cervix: a bimodal treatment strategy.

Authors:  R J Lotocki; G V Krepart; M Paraskevas; G Vadas; M Heywood; F K Fung
Journal:  Gynecol Oncol       Date:  1992-03       Impact factor: 5.482

8.  IMP3 predicts aggressive superficial urothelial carcinoma of the bladder.

Authors:  Lioudmila Sitnikova; Gary Mendese; Qin Liu; Bruce A Woda; Di Lu; Karen Dresser; Sambit Mohanty; Kenneth L Rock; Zhong Jiang
Journal:  Clin Cancer Res       Date:  2008-03-15       Impact factor: 12.531

9.  IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.

Authors:  Otto Walter; Manju Prasad; Shaolei Lu; Robert M Quinlan; Kathryn L Edmiston; Ashraf Khan
Journal:  Hum Pathol       Date:  2009-08-19       Impact factor: 3.466

10.  Histopathologic classification of cervical carcinomas and recognition of mucin-secreting squamous carcinomas.

Authors:  T J Colgan; M Auger; J R McLaughlin
Journal:  Int J Gynecol Pathol       Date:  1993-01       Impact factor: 2.762

View more
  1 in total

1.  Invasive stratified mucin-producing carcinoma (ISMC) of uterine cervix: description of pathological findings and prognosis factors in a series of 15 Chinese patients.

Authors:  Ting Lin; Wei Wang; Lian Xu; Ying He
Journal:  Arch Gynecol Obstet       Date:  2022-04-08       Impact factor: 2.493

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.